Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies. To accomplish this mission, we are dedicated to achieving these goals in Washington, D.C. and across the country.

Featured Blogs

Timely reauthorization of PDUFA and BsUFA is vital to the FDA’s review of medicines

Andrew Powaleny
PhRMA urges policymakers to act soon to pass these vital agreements. Patients are counting on them.

New data: The 340B program is driving up costs for patients and our health care system

Nicole Longo
Fresh data show that 340B may actually be driving up costs for some patients and our health care system as whole.

Navigating the patient experience: Burdens and barriers standing between patients and their care

Mark Keida
Health care affordability is not the only hurdle facing patients, according to PhRMA’s third Patient Experience Survey (PES).